This meta-analysis compared percutaneous thermal ablation (PTA) with robot-assisted partial nephrectomy (RAPN) for patients with localized renal cell carcinoma. The review included data from 2,516 patients across various studies. Researchers looked at local recurrence, recurrence-free survival, and overall survival among other outcomes.
The study found that PTA was associated with a significantly higher rate of local recurrence compared with RAPN. However, there were no significant differences between the two techniques regarding overall survival, cancer-specific survival, or metastatic progression. Major complication rates and estimated glomerular filtration rate variations also showed no significant differences.
The evidence suggests that while PTA remains an appropriate option for carefully selected high-risk patients, the higher local recurrence rate and need for rigorous post-treatment surveillance should be considered. The study notes that evidence on how tumor complexity influences these outcomes remains limited. Patients should discuss these findings with their doctors to make informed decisions about their care.